Document Detail

Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis.
MedLine Citation:
PMID:  16188899     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Patients undergoing chronic haemodialysis frequently have elevated serum cardiac troponin T (cTnT) levels resulting in difficulty in diagnosing acute coronary syndromes (ACS) in these patients. We sought to determine whether: (i) cTnT concentrations were consistent over time; (ii) intradialytic changes in cTnT levels were due to haemoconcentration; (iii) baseline cTnT levels predicted subsequent mortality or ACS. METHODS: We measured serial pre- and post-dialysis cTnT concentrations in 75 asymptomatic patients undergoing chronic haemodialysis at baseline, and at 48 h, 8 months and 15 months. At 15 months, we also measured pre- and post-dialysis haematocrit levels in order to adjust the post-dialysis cTnT concentration for the effect of ultrafiltration. Kaplan-Meier survival curves, log-rank tests and Cox models were employed to determine whether baseline cTnT levels predicted death or ACS within 18 months. RESULTS: Thirty-five (47%) patients had a baseline pre-dialysis cTnT concentration in the diagnostic range for an ACS (cTnT > or = 0.03 microg/l). There was a strong correlation between serial cTnT concentrations in individual patients (P<0.0001 for each time point). The median cTnT concentration was significantly greater post- than pre-dialysis (P<0.01 for each serial analysis); however, there was no significant difference following correction of post-dialysis cTnT levels for the effect of haemoconcentration (P = 0.48). Elevated baseline cTnT levels were associated with an increased risk of mortality or ACS at 18 months (P = 0.0015). CONCLUSION: In asymptomatic patients on haemodialysis, serum cTnT concentrations are frequently elevated, and they rise during dialysis due to haemoconcentration. cTnT levels fluctuate minimally in individual patients in the medium term, therefore annual measurements may be useful reference points in the diagnosis of chest pain and in the prediction of ACS and mortality.
Bryan Conway; Maureen McLaughlin; Peter Sharpe; John Harty
Related Documents :
9342579 - Pharmacokinetics and pharmacodynamic effects of the angiotensin ii antagonist valsartan...
2847529 - Familial resemblance of plasma angiotensin-converting enzyme level: the nancy study.
12773449 - Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyper...
15149319 - Angiotensin administration stimulates renal 11 beta-hydroxysteroid dehydrogenase activi...
8151269 - Effects of captopril on renal function in healthy uninephrectomized subjects and in hea...
1269109 - The role of angiotensins in aldosterone production.
7724029 - Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis re...
3507379 - Changes of elemental concentrations around/on the rat sperm plasma membrane during matu...
14676459 - Serum estradiol concentration as measured by hplc-ria and bone mineral density in postm...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2005-09-27
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  20     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-11-18     Completed Date:  2006-02-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  2759-64     Citation Subset:  IM    
Nephrology Unit, Daisy Hill Hospital, 5 Hospital Road, Newry, Co. Down, Northern Ireland. BT35 8DR.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Coronary Disease / blood,  diagnosis*,  etiology
Diagnosis, Differential
Follow-Up Studies
Kidney Failure, Chronic / blood,  therapy
Renal Dialysis / adverse effects*
Retrospective Studies
Risk Factors
Troponin T / blood*
Reg. No./Substance:
0/Biological Markers; 0/Troponin T

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Patient characteristics rather than the type of dialyser predict the variability of endothelial deri...
Next Document:  Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of nor...